{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:21:55Z","timestamp":1781594515540,"version":"3.54.5"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T00:00:00Z","timestamp":1355443200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051553","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T22:38:18Z","timestamp":1355524698000},"page":"e51553","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["The Mitochondria-Targeted Antioxidants and Remote Kidney Preconditioning Ameliorate Brain Damage through Kidney-to-Brain Cross-Talk"],"prefix":"10.1371","volume":"7","author":[{"given":"Denis N.","family":"Silachev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay K.","family":"Isaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina B.","family":"Pevzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubava D.","family":"Zorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Stelmashook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana V.","family":"Novikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor Y.","family":"Plotnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir P.","family":"Skulachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry B.","family":"Zorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2007.02.007","article-title":"Mitochondrial targeting of quinones: therapeutic implications","volume":"7","author":"HM Cocheme","year":"2007","journal-title":"Mitochondrion"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1134\/S0006297907120139","article-title":"A biochemical approach to the problem of aging: \u201cmegaproject\u201d on membrane-penetrating ions. The first results and prospects","volume":"72","author":"VP Skulachev","year":"2007","journal-title":"Biochemistry (Mosc)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1134\/S0006297908120055","article-title":"Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence","volume":"73","author":"VN Anisimov","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1134\/S0006297908120018","article-title":"Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies","volume":"73","author":"YN Antonenko","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1134\/S000629790812002X","article-title":"Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke)","volume":"73","author":"LE Bakeeva","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1134\/S0006297908120043","article-title":"Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals","volume":"73","author":"VV Neroev","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.M009093200","article-title":"Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties","volume":"276","author":"GF Kelso","year":"2001","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1134\/S0006297909120165","article-title":"New data on biochemical mechanism of programmed senescence of organisms and antioxidant defense of mitochondria","volume":"74","author":"VP Skulachev","year":"2009","journal-title":"Biochemistry (Mosc)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1134\/S0006297910020045","article-title":"New-generation Skulachev ions exhibiting nephroprotective and neuroprotective properties","volume":"75","author":"EY Plotnikov","year":"2010","journal-title":"Biochemistry (Mosc)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbadis.2010.09.008","article-title":"Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia\/reperfusion","volume":"1812","author":"EY Plotnikov","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"10291","DOI":"10.1523\/JNEUROSCI.22-23-10291.2002","article-title":"Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model","volume":"22","author":"K Ruscher","year":"2002","journal-title":"J Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ki.2009.460","article-title":"Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization","volume":"77","author":"A Paliege","year":"2010","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Hagen T (2012) Oxygen versus reactive oxygen in the regulation of HIF-1alpha: The Balance Tips. Biochem Res Int: doi:10.1155\/2012\/436981.","DOI":"10.1155\/2012\/436981"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"32253","DOI":"10.1074\/jbc.271.50.32253","article-title":"Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit","volume":"271","author":"LE Huang","year":"1996","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"M Ivan","year":"2001","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"P Jaakkola","year":"2001","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/FJC.0b013e31815d88c9","article-title":"Possible involvement of erythropoietin in remote renal preconditioning-induced cardioprotection in rats","volume":"51","author":"V Diwan","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00024382-199708000-00003","article-title":"Mechanisms of ischemic preconditioning","volume":"8","author":"T Ishida","year":"1997","journal-title":"Shock"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jss.2007.12.747","article-title":"Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury\u2013a review","volume":"150","author":"N Tapuria","year":"2008","journal-title":"J Surg Res"},{"key":"ref20","first-page":"A118","article-title":"Brief renal occlusion and reperfusion reduces myocardial infarct size in rabbits","volume":"7","author":"TB McClanahan","year":"1993","journal-title":"FASEB J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI19906","article-title":"Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore","volume":"113","author":"M Juhaszova","year":"2004","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/sj.ki.5002568","article-title":"The role of mitochondria in oxidative and nitrosative stress during ischemia\/reperfusion in the rat kidney","volume":"72","author":"EY Plotnikov","year":"2007","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"EZ Longa","year":"1989","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10517-009-0489-z","article-title":"Comparative evaluation of two methods for studies of experimental focal ischemia: magnetic resonance tomography and triphenyltetrazoleum detection of brain injuries","volume":"147","author":"DN Silachev","year":"2009","journal-title":"Bull Exp Biol Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0361-9230(91)90240-K","article-title":"Quantitative comparison of magnetic resonance imaging (MRI) and histologic analyses of focal ischemic damage in the rat","volume":"26","author":"FC Barone","year":"1991","journal-title":"Brain Res Bull"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(00)00409-X","article-title":"Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats","volume":"400","author":"J Jolkkonen","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jnr.490420510","article-title":"Serum-free B27\/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus","volume":"42","author":"GJ Brewer","year":"1995","journal-title":"J Neurosci Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1083\/jcb.85.3.890","article-title":"Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue","volume":"85","author":"KD McCarthy","year":"1980","journal-title":"J Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-6147(00)88999-3","article-title":"Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs?","volume":"16","author":"AJ Hunter","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/092986708783497337","article-title":"Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging","volume":"15","author":"JE Slemmer","year":"2008","journal-title":"Curr Med Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cardiores.2003.10.025","article-title":"New concepts in reactive oxygen species and cardiovascular reperfusion physiology","volume":"61","author":"LB Becker","year":"2004","journal-title":"Cardiovasc Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1096\/fj.05-3718com","article-title":"Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury","volume":"19","author":"VJ Adlam","year":"2005","journal-title":"FASEB J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1442-200X.2008.02705.x","article-title":"Neonatal rat hypoxia-ischemia: Effect of the anti-oxidant mitoquinol, and S-PBN","volume":"50","author":"CE Hobbs","year":"2008","journal-title":"Pediatr Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00232-008-9108-6","article-title":"Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments","volume":"222","author":"YN Antonenko","year":"2008","journal-title":"J Membr Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1134\/S0006297912090052","article-title":"Mitochondria targeted plastoquinone antioxidant SkQR1 decreases trauma-induced neurological deficit in rat","volume":"77","author":"NK Isaev","year":"2012","journal-title":"Biochemistry (Mosc)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2174\/138945011795528859","article-title":"Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies","volume":"12","author":"MV Skulachev","year":"2011","journal-title":"Curr Drug Targets"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ki.1997.69","article-title":"Effects of antioxidant vitamins on renal and hepatic erythropoietin production","volume":"51","author":"W Jelkmann","year":"1997","journal-title":"Kidney Int"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1210\/endo.140.2.6529","article-title":"Effects of pro- and antioxidative compounds on renal production of erythropoietin","volume":"140","author":"I Neumcke","year":"1999","journal-title":"Endocrinology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0034-5687(98)00080-2","article-title":"Effects of modulators of the production and degradation of hydrogen peroxide on erythropoietin synthesis","volume":"114","author":"O Canbolat","year":"1998","journal-title":"Respir Physiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.33549\/physiolres.931590","article-title":"The comparison of antioxidant and hematological properties of N-acetylcysteine and alpha-lipoic acid in physically active males","volume":"58","author":"A Zembron-Lacny","year":"2009","journal-title":"Physiol Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1007\/s00421-011-1893-4","article-title":"Effect of N-acetyl-cysteine and hyperoxia on erythropoietin production","volume":"111","author":"M Momeni","year":"2011","journal-title":"Eur J Appl Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V99.5.1552","article-title":"Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity","volume":"99","author":"W Hildebrandt","year":"2002","journal-title":"Blood"},{"key":"ref43","first-page":"785","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature","volume":"378","author":"DA Cross","year":"1995"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCRESAHA.109.197996","article-title":"Role of glycogen synthase kinase-3beta in cardioprotection","volume":"104","author":"M Juhaszova","year":"2009","journal-title":"Circ Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-4159.2004.02422.x","article-title":"Glycogen synthase kinase 3: a drug target for CNS therapies","volume":"89","author":"RV Bhat","year":"2004","journal-title":"J Neurochem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvq206","article-title":"Mitochondrial kinase signalling pathways in myocardial protection from ischaemia\/reperfusion-induced necrosis","volume":"88","author":"T Miura","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000314310","article-title":"Novel insights into lithium\u2019s mechanism of action: neurotrophic and neuroprotective effects","volume":"62","author":"JA Quiroz","year":"2010","journal-title":"Neuropsychobiology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2007.03.001","article-title":"Role of erythropoietin in the brain","volume":"64","author":"CT Noguchi","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-008-9808-3","article-title":"Signal mechanism activated by erythropoietin preconditioning and remote renal preconditioning-induced cardioprotection","volume":"315","author":"V Diwan","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/hrt.2011.223867","article-title":"Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial","volume":"97","author":"AJ Ludman","year":"2011","journal-title":"Heart"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2011.592","article-title":"Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial","volume":"305","author":"SS Najjar","year":"2011","journal-title":"JAMA"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ahj.2011.11.005","article-title":"Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial","volume":"163","author":"F Prunier","year":"2012","journal-title":"Am Heart J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","article-title":"Recombinant human erythropoietin in the treatment of acute ischemic stroke","volume":"40","author":"H Ehrenreich","year":"2009","journal-title":"Stroke"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2119\/molmed.2011.00259","article-title":"Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients","volume":"17","author":"H Ehrenreich","year":"2011","journal-title":"Mol Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurjhf\/hfr002","article-title":"A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure","volume":"13","author":"M Bergmann","year":"2011","journal-title":"Eur J Heart Fail"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T12:41:39Z","timestamp":1643892099000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051553"}},"subtitle":[],"editor":[{"given":"Valdur","family":"Saks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,14]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051553","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,14]]}}}